Key Details
- The audio recording is for the conference call held on 30th July 2026 regarding the company's unaudited financial results (both standalone and consolidated) for the quarter ended 30th June 2026.
- This communication serves as a follow-up to the company's previous letter dated 20th July 2026.
- The disclosure is made specifically under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Availability Information
The audio recording is available on the company's official website at: https://www.piramalpharma.com/financial-reports